Expressiona and Diagnostic Potential of miRNAs in NSCLC
Completed
- Conditions
- Non Small Cell Lung Cancer
- Registration Number
- NCT05815407
- Lead Sponsor
- Al-Azhar University
- Brief Summary
Its to explore the expression pattern, diagnostic and prognostic potentials of miRs (106b-5p, 601 and 760) in serum of NSCLC patients
- Detailed Description
A retrospective observational study on NSCLC patients, to determine the serum expression levels if some miRNAs in NSCLC patients and to find if having proper diagnostic and prognostic values in early disease detection, and/or staging.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- First time and recently diagnosed NSCLC patient
Exclusion Criteria
- Recurrent NSCLC
- Start of chemotherapy, radiotherapy or surgical intervention
- Previous treatment
- Cancer history
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Determination of the expression By the end of the study (September 2022) Expression profiling of the selected miRNAs
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt
🇪🇬Cairo, Egypt
Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt🇪🇬Cairo, Egypt